CACNA1G and non-small cell lung carcinoma: Here, we demonstrated for the first time that a subset of tumors from an early-stage NSCLC cohort overexpress the T-type VGCC 3.1 (Cav3.1) by tissue microarray immunohistochemistry analysis.